We are live on ! Find out more
NSPR icon

InspireMD

46 hedge funds and large institutions have $41.2M invested in InspireMD in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

12% more capital inflows, than outflows

Capital inflows: $4.66M | Capital outflows: $4.17M

10% more funds holding

Funds holding: 42 → 46 (+4)

0.2% more ownership

Funds ownership: 54.5% → 54.7% (+0.2%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

50% less call options, than puts

Call options by funds: $9K | Put options by funds: $18K

Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
12
Increased
7
Reduced
6
Closed
8
Calls
$9K
Puts
$18K
Net Calls
-$9K
Net Calls Change
+$3K

NSPR Hedge Fund Activity: Q4 2025 in Review

46 of the 8,313 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2025, worth a combined $41.2M — down 25% from $54.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NSPR positions and 8 closed out — a net gain of 4 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was OrbiMed, adding an estimated $2.08M. The largest seller was Ghisallo Capital Management, exiting entirely with an estimated $2.22M sold.

  • 46 institutional investors held InspireMD (NSPR) as of Q4 2025, up from 42 in Q3 2025.
  • Funds reported $41.2M of InspireMD stock for Q4 2025, down 25% quarter-over-quarter.
  • 12 funds opened new InspireMD positions in Q4 2025 and 8 closed out, a net change of +4 holders.
  • The largest InspireMD buyer in Q4 2025 was OrbiMed, an estimated $2.08M added.
  • The largest InspireMD seller in Q4 2025 was Ghisallo Capital Management, an estimated $2.22M sold.

Based on aggregated 13F filings for Q4 2025.